Back to Search
Start Over
MA26.03 Activity of Osimertinib and the Selective RET Inhibitor BLU-667 in an EGFR-Mutant Patient with Acquired RET Rearrangement.
- Source :
- Journal of Thoracic Oncology; Oct2018 Supplement, Vol. 13, pS451-S451, 1p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 15560864
- Volume :
- 13
- Database :
- Complementary Index
- Journal :
- Journal of Thoracic Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 132778739
- Full Text :
- https://doi.org/10.1016/j.jtho.2018.08.540